Sánchez VLD, Gutiérrez RM, Reyes SME, González AVM, D’Ector LDM

Language: Spanish
References: 24
Page: 203-207
PDF size: 79.79 Kb.

ABSTRACT

Objective: To find inflammatory markers to increase sensitivity of septic continuum. Design: Prospective study during a fifteen-month period. Setting: Polyvalent ICU of a private hospital in Mexico City. Patients: A total of 136 patients (mean age 59.5 ± 15.9 yrs) were included. Interventions: None. Measurements and main results: The following data were registered daily: SIRS criteria, sepsis, severe sepsis and septic shock, acid-base balance, fluid intake, fluid balance, lymphocytes and monocytes count, erythrocyte sedimentation rate, C-reactive protein, fibrinogen, and APACHE II, Brussels and TISS-28 scores. It was found SIRS (n = 117), sepsis (n = 39), severe sepsis (n = 29), and septic shock (n = 9). Significant variables were lymphocytes (p ‹ 0.005), fluid intake (p ‹ 0.001), TISS-28 (p ‹ 0.001) and Brussels score (p ‹ 0.001). Conclusion: Inflammatory markers are useful to evaluate the course of sepsis in critically ill patients.

REFERENCES

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Comittee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.

2. Bone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992;268:3452-5.

3. Knaus WA, Draper EA, Wagner DP et al. APACHE II: A severity of disease classification. Crit Care Med 1985;13: 818-29.

4. Bernard GR, Doig G, Hudson LD et al. Quantification of organ failure for clinical trials and clinical practice. Am J Respir Crit Care Med 1995;151:A323.

5. Teasdale G, Jennett B. Assessment of coma and impaired consciousness, a practical scale. Lancet 1974;2:81-4.

6. Miranda DR, Rijk A, Schaufeli. Simplified Therapeutic Intervention Scoring System. The TISS-28 items-Results from a multicenter study. Crit Care Med 1996;24(1):64-73.

7. Da Silva O, Ohlsson A, Kenyon C. Accuracy of leukocyte indices and C-reactive protein for diagnosis of neonatal sepsis: a critical review. Pediatric Infectious Disease Journal 1995;14:362-66.

8. Krediet T, Gerards L, Fleer A, van Stekelenburg G. The predictive value of CRP and I/T-ratio in neonatal infection. J Perinat Med 1992;20:479-85.

9. DiPiro JT, Hamilton RG, Howdieshell TR, Adkinson NF Jr, Mansberger AR Jr. Total IgE in plasma is elevated after traumatic injury and is associated with sepsis syndrome. Annals of Surgery 1992;215:460-5.

10. Sullivan JS, Kilpatrick L, Costarino AT Jr, Lee SC, Harris MC. Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediat 1992;120:510-5.

11. Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 1992;60: 2835-42.

12. Waydhas C, Nast-Kolb D, Jochum M, Trupka A, Lenk S, Fritz H et al. Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg 1992;127:460-7.

13. Nuijens JH, Abbink JJ, Wachtfogel YT, Colman RW, Eerenberg AJ, Dors D et al. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 1992;119: 159-68.

14. Krafte-Jacobs B, Bock GH. Circulating erythropoietin and interleukin-6 concentrations increase in critically ill children with sepsis and septic shock. Crit Care Med 2001;29(Suppl.):S151-S155.

15. Nupponen I, Andersson S, Jarvenpaa AL, Kautiainen HBA, Repo H. Neutrophil CD11b Expression and Circulating Interleukin-8 as Diagnostic Markers for Early-Onset Neonatal Sepsis. Pediatrics 2001;108:e12.

16. Fisher ChJ Jr, Yan SB. Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 2000;28(Suppl):S49-S56.

17. Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R et al. Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. [Article]. Crit Care Med 2000;28:3171-3176.

18. Hatherill M, Tibby SM, Sykes K, Turner Ch, Murdoch IA. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leukocyte count. Arch Dis Child 1999;81:417-421.

19. Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Kohl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000; 28:2793-2798.

20. Kreuzer E, Kaab S, Pilz G, Werdan K. Early prediction of septic complications after cardiac surgery by APACHE II score. Eur J Cardio-Thorac Surg 1992;6:524-8.

21. Russell JA, Singer J, Bernard GR, Wheeler A, Fulkerson W, Hudson L et al. Changing pattern of organ dysfunction in early human sepsis is related to mortality. Crit Care Med 2000;28:3405-3411.

22. Calvano SE, Coyle SM, Barbosa KS, Barie PS, Lowry SF. Multivariate Analysis of 9 Disease-Associated Variables for Outcome Prediction in Patients With Sepsis. Archives of Surgery 1998;133:1347-1350.

23. Boldt J, Müller M, Mentges D, Papsdorf M, Hempelmann. Volume therapy in the critically ill: is there a difference? Intensive Care Med 1998;24:28-36.

24. Rosenthal MH. Intraoperative fluid management-What and how much? Chest 1999;115:106S-112S.